European School Oncology
Oncology e-learning

Your free Education just a click away!

Support our work
DONATE NOW

#e_ESO

Latest recorded sessions

21
Mar 2019
18:15-19:00 CET
E-session 474
Grandround

Immune therapy in urothelial cancer: today and tomorrow

CME accredited

Expert:

Yohann Loriot, expert of session 'Immune therapy in urothelial cancer: today and tomorrow'

Yohann Loriot Gustave Roussy Cancer Campus Villejuif, France

Discussant: Dominik Berthold, University Hospital of Canton Vaud, Lausanne, Switzerland

Share on:
Add to My Agenda

14
Mar 2019
18:15-19:00 CET
E-session 473
Grandround

Pathological diagnosis of rare cancers

CME accredited

Expert:

Angelo Paolo Dei Tos, expert of session 'Pathological diagnosis of rare cancers'

Angelo Paolo Dei Tos Pathologist University of Padua School of Medicine Padua, Italy

Discussant: Paolo Casali, National Cancer Institute - IRCCS Foundation, Milan, Italy

Share on:
Add to My Agenda

09
Mar 2019
12:00-13:00 CET
E-session 472000
Facebook session

Adjuvant chemotherapy for soft tissue sarcoma

NO CME

Expert:

Andri Papakonstantinou, expert of session 'Adjuvant chemotherapy for soft tissue sarcoma'

Andri Papakonstantinou Karolinska Institute & Karolinska University Hospital Stockholm, Sweden

Share on:
Add to My Agenda

07
Mar 2019
18:15-19:00 CET
E-session 472
Grandround

Recognising depression and suicidal ideation in the cancer setting (held in collaboration with EONS)

CME accredited

Expert:

Friedrich Stiefel, expert of session 'Recognising depression and suicidal ideation in the cancer setting (held in collaboration with EONS)'

Friedrich Stiefel University Hospital Lausanne Lausanne, Switzerland

Discussant: Mary Moriarty, Psycho-Oncologist, St Vincent's University Hospital, Dublin, Ireland

Share on:
Add to My Agenda
Further materials
EDUCATIONAL MATERIALS
FUTURE SESSIONS

Contact Form

Future live sessions

26
Mar 2019
15:00 CET
Grandround

Cancer of unknown primary

NO CME

Experts:

Nicholas Pavlidis, expert of session 'Cancer of unknown primary'

N. Pavlidis
Ioannina
Greece

28
Mar 2019
18:15 CET
Debate

Debate: should be  RT still part of treatment for Hodgkin lymphoma? (Part II)

CME accredited

Experts:

Umberto Ricardi, expert of session 'Debate: should be  RT still part of treatment for Hodgkin lymphoma? (Part II)'

U. Ricardi
Turin
Italy

Astrid Pavlovsky, expert of session 'Debate: should be  RT still part of treatment for Hodgkin lymphoma? (Part II)'

A. Pavlovsky
Buenos Aires
Argentina

e-ESO hes teamed up with
We Oncologists to create

"We Oncologists & ESO Presents"
a page for:

#Oncology #Education

Ulm university

The e-ESO sessions are part of the Master-Online Study Program Advanced Oncology of Ulm University


www.uni-ulm.de
The mastermind winners of e-session 473


1.Marina Puchinskaya
2.Juan Carlos Haro Varas
3.Domenico Attilio Romanello

Recently Published Articles:

www.cancerworld.net
Top